Antithrombotic treatment after transcatheter patent foramen ovale closure in patients with previous cryptogenic stroke.
Event: ESC Preventive Cardiology 2024
Topic: Congenital Heart Disease
Session: Assessing and managing cardiovascular risk after interventions and surgery
Safety and efficacy of antiplatelet cessation after transcatheter patent foramen ovale closure.
Event: ESC Preventive Cardiology 2024
Topic: Congenital Heart Disease
Session: Assessing and managing cardiovascular risk after interventions and surgery
Management of patent foramen ovale; findings from a nationwide survey
Event: ESC Preventive Cardiology 2024
Topic: Congenital Heart Disease
Session: Diagnosis and management of cardiovascular risk in high-risk patients
Trends in antithrombotic treatment after cryptogenic stroke and prior transcatheter patent foramen ovale closure.
Event: ESC Preventive Cardiology 2024
Topic: Congenital Heart Disease
Session: Assessing and managing cardiovascular risk in patients with acute cardiac syndromes and stroke
Thirty-days versus standard duration of dual antiplatelet treatment after percutaneous coronary interventions: a systematic review and meta-analysis
Event: ESC Congress 2022
Topic: Antiplatelet Drugs
Session: Short and long-term antiplatelet therapy in clinical practice
ESC 365 is supported by
